Vancouver, British Columbia–(Newsfile Corp. – December 24, 2025) – Silverco Mining Ltd. (TSXV: SICO) (“Silverco” or the “Company”) announces that at the request of CIRO, Silverco wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. About Silverco […]
ABU DHABI, United Arab Emirates, Dec. 24, 2025 (GLOBE NEWSWIRE) — Vanar, an AI-native blockchain infrastructure company, joined global payments and capital markets leaders at Abu Dhabi Finance Week (ADFW) 2025, marking a visible presence across multiple flagship forums focused on tokenized capital, real-world settlement, and the next generation of financial infrastructure. Vanar's participation was
Vanar and Worldpay Take the Stage at Abu Dhabi Finance Week to Advance Agentic Payments GlobeNewswire December 24, 2025 ABU DHABI, United Arab Emirates, Dec. 24, 2025 (GLOBE NEWSWIRE) — Vanar, an AI-native blockchain infrastructure company, joined global payments and capital markets leaders at Abu Dhabi Finance Week (ADFW) 2025, marking a visible presence across
(NYSE:TEVA),(TASE:TEVA.TA),(TASE:TEVA), The two updates underscore Teva's strong execution of its Pivot to Growth strategy and commitment to financial discipline. Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive from stable S&P upgraded Teva to BB+ from BB, with a stable outlook TEL AVIV, Israel, Dec. 24, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries
S&P Global Ratings Upgrades Teva to 'BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive GlobeNewswire December 24, 2025 The two updates underscore Teva's strong execution of its Pivot to Growth strategy and commitment to financial discipline. Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive
DUBAI, United Arab Emirates, Dec. 24, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) continues to move closer to its V1 protocol launch while one of the most active stages of its token distribution reaches a critical point. Phase 6 of the MUTM allocation is now over 99% filled, reflecting sustained demand across multiple weeks rather
(Other OTC:MTWO),(OTC US:MTWO),(NYSE:SOAR), Strategic Roadmap is Set for Further Advancing the Business and Capital Markets Plans in 2026 Atlanta, GA and Reno, NV, Dec. 24, 2025 (GLOBE NEWSWIRE) — M2i Global, Inc. (“M2i,” the “Company,” “we,” “our” or “us”) (OTCQB: MTWO), a company specializing in the development and execution of a complete global value supply
(CNSX:MDMA.CN),(CNSX:MDMA),(OTC US:MDXXF),(Other OTC:MDXXF), TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo(TM) MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial results for the periods
New Crypto Mutuum Finance (MUTM) Advances Toward V1 Launch as Phase 6 Allocation is Over 99% GlobeNewswire December 24, 2025 DUBAI, United Arab Emirates, Dec. 24, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) continues to move closer to its V1 protocol launch while one of the most active stages of its token distribution reaches a
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements GlobeNewswire December 24, 2025 TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo(TM) MDMA and novel derivatives of MDMA (MDXX